Charles Craddock
University Hospital Birmingham NHS Foundation Trust · University of Birmingham
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Charles Craddock as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:17 UTC. Open this list on ClinicalTrials.gov
- Ph2/Ph3NCT04217278 · A Trial of Treatments to Assess the Effects on Outcome of Adults With AML and MDS Undergoing Allogeneic SCTUniversity of Birmingham · active not recruiting · Acute Myeloid Leukaemia, High-risk Myelodysplastic Syndrome · principal investigator
- Ph3NCT04173533 · Randomised Study of Oral Azacitidine vs Placebo Maintenance in AML or MDS Patients After Allo-SCTUniversity of Birmingham · completed · Acute Myeloid Leukemia, Myelodysplasia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:17 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in acute myeloid leukemia, ranked by citations from NIH iCite, fetched 2026-11-12 10:17 UTC. The ranking covers the 200 most relevant of 16 PubMed records, and a shared surname and initials can bring in a namesake. All 16 on PubMed
- 353 citationsRCR 9.0
- Addition of gemtuzumab ozogamicin to induction chemotherapy improves survival in older patients with acute myeloid leukemia.J Clin Oncol · 2012333 citationsRCR 8.0
- 190 citationsRCR 4.4
- 151 citationsRCR 6.9
- Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid Leukemia.J Clin Oncol · 2021141 citationsRCR 8.5
- CC-486 Maintenance after Stem Cell Transplantation in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes.Biol Blood Marrow Transplant · 2018136 citationsRCR 5.0
- Genetically distinct leukemic stem cells in human CD34- acute myeloid leukemia are arrested at a hemopoietic precursor-like stage.J Exp Med · 2016131 citationsRCR 3.6
- Outcome of Azacitidine Therapy in Acute Myeloid Leukemia Is not Improved by Concurrent Vorinostat Therapy but Is Predicted by a Diagnostic Molecular Signature.Clin Cancer Res · 201776 citationsRCR 2.3
- Targeting the arginine metabolic brake enhances immunotherapy for leukaemia.Int J Cancer · 201972 citationsRCR 2.3
- Combination Lenalidomide and Azacitidine: A Novel Salvage Therapy in Patients Who Relapse After Allogeneic Stem-Cell Transplantation for Acute Myeloid Leukemia.J Clin Oncol · 201960 citationsRCR 2.3